Q1FY27 results: revenue up around 28 percent, to divest Nasense Labs stake
NACLIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 3.0 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NACL Industries posted Q1FY27 results with standalone revenue at about Rs 530.7 crore versus Rs 415.5 crore year ago, up around 28 percent. Board also approved sale of entire stake in associate Nasense Labs for about Rs 8.15 crore to an unrelated buyer. Auditor S.R. Batliboi gave an unmodified review. Rights issue funds use report also tabled.
Strong top-line growth and clean audit opinion; small associate divestment with minimal financial impact.